SMARCA1 and cancer: As LSD1 is highly expressed in SCCOHT cell lines and interacts with members of the SWI/SNF complex to regulate gene expression [55, 68, 69], it is an ideal therapeutic target for the treatment of SCCOHT and potentially other SWI/SNF loss-of-function- dependent cancers.